切换至 "中华医学电子期刊资源库"

中华脑血管病杂志(电子版) ›› 2021, Vol. 15 ›› Issue (05) : 319 -322. doi: 10.11817/j.issn.1673-9248.2021.05.009

论著

前循环串联病变血管内治疗预后的影响因素分析
彭涛1, 张紫霓1, 朱碧峰1, 但毕堂1,()   
  1. 1. 430000 武汉,江汉大学附属湖北省第三人民医院神经内科
  • 收稿日期:2020-08-18 出版日期:2021-10-09
  • 通信作者: 但毕堂

Factors affecting the prognosis of endovascular treatment for anterior circulation tandem lesions

Tao Peng1, Zini Zhang1, Bifeng Zhu1, Bitang Dan1()   

  1. 1. Department of Neurology, Jianghan University Affiliated Third People's Hospital of Hubei Province, Wuhan 430000, China
  • Received:2020-08-18 Published:2021-10-09
  • Corresponding author: Bitang Dan
引用本文:

彭涛, 张紫霓, 朱碧峰, 但毕堂. 前循环串联病变血管内治疗预后的影响因素分析[J/OL]. 中华脑血管病杂志(电子版), 2021, 15(05): 319-322.

Tao Peng, Zini Zhang, Bifeng Zhu, Bitang Dan. Factors affecting the prognosis of endovascular treatment for anterior circulation tandem lesions[J/OL]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2021, 15(05): 319-322.

目的

探讨前循环串联病变血管内治疗预后的影响因素。

方法

回顾性分析2014年1月1日至2019年12月31日湖北省第三人民医院神经内科收治的43例急性前循环串联病变患者的临床资料。按术后90 d改良Rankin量表(mRS)评分进行分组,MRS评分0~2分组为预后良好组,3~6分组为预后不良组。对于年龄、美国国立卫生院脑卒中量表评分(NIHSS)、Albert卒中计划早期CT评分(ASPECTS)和性别、高血压、糖尿病、高脂血症、冠心病、吸烟、心房颤动、静脉溶栓、颈动脉置入支架、取栓次数、血管再通情况、症状性颅内出血等资料进行分析,归纳前循环串联病变血管内治疗预后的影响因素分析。

结果

90 d良好预后组与预后不良组相比较,糖尿病及冠心病发病率更低(2/23 vs 7/20;3/23 vs 10/20),基线ASPECTS评分更高(7.61±2.06)分 vs(5.80±2.57)分,取栓次数(≤3)所占比例高(22/23 vs 10/20),差异均具有统计学意义(χ2=4.473,P=0.034;χ2=6.927,P=0.008;t=2.562,P=0.014;χ2=11.711,P<0.001)。多因素Logistic回归分析显示冠心病(无)(OR=0.049,P=0.007)、取栓次数(≤3次)(OR=0.470,P=0.026)是预后的保护因素,基线ASPECTS评分(OR=1.470,P=0.043)是预后的影响因素。ASPECTS评分的阈值为5分,其敏感度为91.3%,特异度为55.0%,ROC曲线下面积为0.720,P=0.014,95%CI为0.564~0.876。

结论

ASPECTS评分≥5分、取栓次数≤3次、无冠心病的前循环串联病变患者有更大可能获得良好预后。

Objective

To explore the factors affecting the prognosis of endovascular treatment for anterior circulation tandem lesions.

Methods

The retrospective analysis collected the clinical data of 43 patients with acute anterior circulation tandem lesions admitted to Department of Neurology, Jianghan University Affiliated Third People's Hospital of Hubei Province from January 1, 2014 to December 31, 2019. According to the 90-day modified Rankin scale (mRS) after the operation, patients with mRS score 0-2 were defined as the good prognosis group, and patients with 3-6 as the poor prognosis group. For continuous variables such as age, National Institutes of Health Stroke Scale (NIHSS), and baseline Alberta stroke program early CT score (ASPECTS score), t test was used. Chi-square analysis was used for categorical variables such as gender, hypertension, diabetes, hyperlipidemia, coronary heart disease, smoking, atrial fibrillation, intravenous thrombolysis, carotid stent placement, thrombectomy times, vascular recanalization, symptomatic intracranial hemorrhage. Multivariate Logistic analysis was used to evaluate the factors affecting the prognosis of endovascular treatment for anterior circulation tandem lesions.

Results

Compared with the poor prognosis group, the good prognosis group had a lower incidence of diabetes and coronary heart disease(2/23 vs 7/20, χ2=4.473, P=0.034; 3/23 vs 10/20, χ2=6.927, P=0.008), a higher baseline ASPECTS score [(7.61±2.06) vs (5.80±2.57), t=2.562, P=0.014], and fewer thrombus removals (22/23 vs 10/20; χ2=11.711, P<0.001). Multivariate logistic regression analysis showed that no coronary heart disease (OR=0.049, P=0.007) and embolectomy ≤3 times (OR=0.470, P=0.026) were protective factors for prognosis, and baseline aspects score (OR=1.470, P=0.043) was another influence factor for prognosis (P<0.05). The ASPECTS score threshold was 5 points, with the sensitivity of 91.3% and the specificity of 55.0%. The area under the ROC curve was 0.72 (P=0.014, 95% CI 0.564~0.876).

Conclusion

Patients with anterior circulation tandem lesions with an ASPECTS score ≥5 points, thrombectomy times ≤3 times, and no coronary heart disease are more likely to have a good prognosis.

表1 不同预后急性串联病变患者临床资料
表2 急性串联病变患者预后多因素Logistic回归分析
图1 ASPECTS评分预测急性串联病变患者预后的曲线
1
Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke [J]. N Engl J Med, 2015, 372(1): 11-20.
2
Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke [J]. N Engl J Med, 2015, 372(24): 2296-2306.
3
Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke [J]. N Engl J Med, 2015, 372(24): 2285-2295.
4
Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection [J]. N Engl J Med, 2015, 372(11): 1009-1018.
5
Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke [J]. N Engl J Med, 2015, 372(11): 1019-1030.
6
Barber PA, Demchuk AM, Zhang J, et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy [J]. Lancet. 2000, 355(9216): 1670-1674.
7
Logan C, Maingard J, Phan K, et al. Borderline Alberta Stroke Programme Early CT Score patients with acute ischemic stroke due to large vessel occlusion may find benefit with endovascular thrombectomy [J]. World Neurosurg, 2018, 110: e653-e658.
8
Phan K, Saleh S, Dmytriw AA, et al. Influence of ASPECTS and endovascular hrombectomy in acute ischemic stroke: a meta-analysis [J]. J NeuroIntervent Surg, 2019, 11(7): 664-669.
9
Flottmann F, Leischner H, Broocks G, et al. Recanalization rate per retrieval attempt in mechanical thrombectomy for acute ischemic stroke [J]. Stroke, 2018, 49(10): 2523-2525.
10
Seker F, Pfaff J, Wolf M, et al. Correlation of thrombectomy maneuver count with recanalization success and clinical outcome in patients with ischemic stroke [J]. AJNR Am J Neuroradiol, 2017, 38(7): 1368-1371.
11
Jindal G, Carvalho HP, Wessell A, et al. Beyond the first pass: revascularization remains critical in stroke thrombectomy [J]. J Neurointerv Surg, 2019, 11(11): 1095-1099.
12
Coelho A, Lobo M, Gouveia R, et al. Overview of evidence on emergency carotid stenting in patients with acute ischemic stroke due to tandem occlusions: a systematic review and meta-analysis [J]. J Cardiovasc Surg, 2018, 60(6): 693-702.
13
Gogela SL, Gozal YM, Zhang B, et al. Severe carotid stenosis and delay of reperfusion in endovascular stroke treatment: an Interventional Management of Stroke-Ⅲ study [J]. J Neurosurg, 2018, 128(1): 94-99.
14
Papanagiotou P, Haussen DC, Turjman F, et al. Carotid stenting with antithrombotic agents and intracranial thrombectomy leads to the highest recanalization rate in patients with acute stroke with tandem lesions [J]. JACC Cardiovasc Interv, 2018, 11(13): 1290-1299.
15
Jadhav AP, Zaidat OO, Liebeskind DS, et al. Emergent management of tandem lesions in acute ischemic stroke analysis of the stratis registry [J]. Stroke, 2019, 50(2): 428-433.
[1] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[2] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[3] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[4] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[5] 陈樽, 王平, 金华, 周美玲, 李青青, 黄永刚. 肌肉减少症预测结直肠癌术后切口疝发生的应用研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 639-644.
[6] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[7] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[8] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[9] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[10] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[11] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[12] 曾明芬, 王艳. 急性胰腺炎合并脂肪肝患者CT 与彩色多普勒超声诊断参数与其病情和预后的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 531-535.
[13] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[14] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[15] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
阅读次数
全文


摘要